IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
UP-0811343
(2004-03-26)
|
등록번호 |
US-7652077
(2010-02-24)
|
발명자
/ 주소 |
- Cook, William A.
- Hiles, Michael C.
- Kozma, Thomas G.
- Patel, Umesh H.
|
출원인 / 주소 |
- Cook Incorporated
- Cook Biotech, Inc.
- MED Institute Incorporated
|
대리인 / 주소 |
Woodard, Emhardt, Moriarty, McNett & Henry LLP
|
인용정보 |
피인용 횟수 :
20 인용 특허 :
104 |
초록
▼
A graft prostheses (11), materials and method for implanting, transplanting, replacing, or repairing a part of a patient. The graft prosthesis includes a purified, collagen-based matrix structure removed from a submucosa tissue source. The submucosa tissue source is purified by disinfection and remo
A graft prostheses (11), materials and method for implanting, transplanting, replacing, or repairing a part of a patient. The graft prosthesis includes a purified, collagen-based matrix structure removed from a submucosa tissue source. The submucosa tissue source is purified by disinfection and removal steps to deactivate and remove contaminants, thereby making the purified structure biocompatible and suitable for grafting on and/or in a patient.
대표청구항
▼
What is claimed is: 1. A method for obtaining a collagen-based matrix comprising submucosa from a submucosa tissue source comprising: treating a submucosa tissue source that includes submucosa and attached tunica muscularis tissue with an oxidizing disinfecting agent to provide a disinfected submuc
What is claimed is: 1. A method for obtaining a collagen-based matrix comprising submucosa from a submucosa tissue source comprising: treating a submucosa tissue source that includes submucosa and attached tunica muscularis tissue with an oxidizing disinfecting agent to provide a disinfected submucosa tissue source; and removing the collagen-based matrix comprising submucosa from the disinfected submucosa tissue source, said removing including separating amounts of the attached tunica muscularis tissue from the submucosa. 2. The method of claim 1, wherein the submucosa tissue source is from an alimentary tract of a mammal. 3. The method of claim 2, wherein the mammal is a pig. 4. The method of claim 3, wherein the submucosa tissue source is from the small intestine of a pig. 5. The method of claim 1, wherein said treating includes contacting the submucosa tissue source with a liquid medium containing the disinfecting agent, the disinfecting agent is an oxidizing agent. 6. The method of claim 1, wherein the disinfecting agent is a peroxy compound. 7. The method of claim 6, wherein the disinfecting agent is an organic peroxy compound. 8. The method of claim 7, wherein the disinfecting agent is a peracid. 9. The method of claim 8, wherein the peracid is selected from the group consisting of peracetic acid, perpropionic acid and perbenzoic acid. 10. The method of claim 9, wherein the peracid is peracetic acid. 11. The method of claim 8, wherein said treating includes treating the submucosa tissue source with a medium containing an alcohol and the peracid. 12. The method of claim 11, wherein the alcohol has one to about six carbon atoms. 13. The method of claim 12, wherein the alcohol is selected from the group consisting of ethanol, propanols, and butanols. 14. The method of claim 13, wherein the alcohol is ethanol. 15. The method of claim 14, wherein the medium is an aqueous ethanol solution containing from about 0.1% to about 0.3% by volume peracetic acid. 16. The method of claim 8, wherein said treating includes treating the submucosa tissue source with a medium containing the peracid and having a pH of about 2 to about 6. 17. The method of claim 16, wherein the medium has a pH of about 2 to about 4. 18. The method of claim 17, wherein the peracid is peracetic acid, and the medium contains about 0.1% to about 0.3% by volume of peracetic acid. 19. A method for obtaining a collagen-based matrix comprising submucosa from a submucosa tissue source, comprising: providing a submucosa tissue source that includes submucosa and attached tunica muscularis tissue, treating said submucosa tissue source with a sufficient amount of oxidizing disinfecting agent to disinfect said submucosa tissue source; and removing the collagen-based matrix comprising submucosa from said treated submucosa tissue source, said removing including separating amounts of the attached tunica muscularis tissue from the submucosa. 20. The method of claim 19, wherein said submucosa tissue source is from a small intestine. 21. The method of claim 20, wherein said treating includes contacting the submucosa tissue source with an aqueous medium containing the oxidizing agent. 22. The method of claim 19, wherein said treating includes contacting the submucosa tissue source with an aqueous medium containing a peroxy compound. 23. The method of claim 22, wherein the peroxy compound is a peracid. 24. The method of claim 23, wherein the peracid is peracetic acid. 25. The method of claim 24, wherein the medium comprises an alcohol. 26. The method of claim 25, wherein the alcohol is ethanol. 27. The method of claim 24, wherein the small intestine is from a pig. 28. A method for obtaining a collagen-containing matrix from a submucosa tissue source, comprising: providing a submucosa tissue source including submucosa tissue and tunica muscularis tissue attached to the submucosa tissue; wherein the submucosa tissue source is from urinary tract tissue; separating the tunica muscularis tissue from the submucosa tissue; recovering a collagen-containing matrix including the submucosa tissue separated from the tunica muscularis tissue; wherein said collagen-containing matrix comprises the submucosa tissue and lamina propria tissue; wherein said collagen-containing matrix exhibits an endotoxin level of less than 1 endotoxin unit per gram; wherein said collagen-containing matrix exhibits a bioburden of less than 0.5 colony forming units per gram; wherein said collagen-containing matrix retains glycosaminoglycans, glycoproteins, proteoglycans and growth factors from said tissue source, and said growth factors include basic fibroblast growth factor; and wherein said collagen-containing matrix exhibits a capacity to induce angiogenesis. 29. The method of claim 28, also comprising contacting the submucosa tissue with an aqueous solution containing peracetic acid. 30. The method of claim 28, wherein the submucosa tissue source is porcine.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.